Literature DB >> 29535143

Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions.

Adrian F Daly1, Emilie Castermans2, Lindsey Oudijk3, Mirtha A Guitelman4, Pablo Beckers5, Iulia Potorac1, Sebastian J C M M Neggers6, Nathalie Sacre2, Aart-Jan van der Lely6, Vincent Bours2, Wouter W de Herder6, Albert Beckers1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29535143     DOI： 10.1530/ERC-18-0065

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  17 in total

1.  MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.

Authors:  Arnaud Augert; Haritha Mathsyaraja; Ali H Ibrahim; Brian Freie; Michael J Geuenich; Pei-Feng Cheng; Sydney P Alibeckoff; Nan Wu; Joseph B Hiatt; Ryan Basom; Adi Gazdar; Lucas B Sullivan; Robert N Eisenman; David MacPherson
Journal:  Cancer Cell       Date:  2020-05-28       Impact factor: 31.743

Review 2.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

Review 3.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

4.  Bilateral Pheochromocytoma with Germline MAX Variant without Family History.

Authors:  Shinnosuke Hata; Mai Asano; Hiroyuki Tominaga; Masahide Hamaguchi; Fumiya Hongo; Takeshi Usui; Eiichi Konishi; Michiaki Fukui
Journal:  Clin Pract       Date:  2022-05-07

Review 5.  The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.

Authors:  Paraskevi Xekouki; Ana Brennand; Ben Whitelaw; Karel Pacak; Constantine A Stratakis
Journal:  Horm Metab Res       Date:  2018-10-01       Impact factor: 2.936

Review 6.  The Genetics of Pituitary Adenomas.

Authors:  Christina Tatsi; Constantine A Stratakis
Journal:  J Clin Med       Date:  2019-12-21       Impact factor: 4.241

7.  A Novel, Likely Pathogenic MAX Germline Variant in a Patient With Unilateral Pheochromocytoma.

Authors:  César Ernesto Lam-Chung; Larissa López Rodríguez; Jazmín Arteaga Vázquez; Yanin Chávarri-Guerra; Rebeca Arízaga-Ramírez; Orlando Falcon Antonio; Jazmín De Anda González; María Aurelia López-Hernández; Jeffrey N Weitzel; Danielle Castillo; Francisco Javier Gómez-Pérez; Daniel Cuevas-Ramos
Journal:  J Endocr Soc       Date:  2021-06-03

8.  A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma.

Authors:  Michelle Maher; Federico Roncaroli; Nigel Mendoza; Karim Meeran; Natalie Canham; Monika Kosicka-Slawinska; Birgitta Bernhard; David Collier; Juliana Drummond; Kassiani Skordilis; Nicola Tufton; Anastasia Gontsarova; Niamh Martin; Márta Korbonits; Florian Wernig
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-07-21

Review 9.  Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma.

Authors:  Mouna Tabebi; Peter Söderkvist; Lasse D Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-16       Impact factor: 5.555

10.  Familial Acromegaly and Bilateral Asynchronous Pheochromocytomas in a Female Patient With a MAX Mutation: A Case Report.

Authors:  Elizaveta Mamedova; Evgeny Vasilyev; Vasily Petrov; Svetlana Buryakina; Anatoly Tiulpakov; Zhanna Belaya
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-31       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.